Skip to main contentAll experts

Marc H. Scheetz, Pharm.D., M.SC

Associate Dean

College of Pharmacy-Downers Grove

Orcid identifier0000-0002-1091-6130 (opens in a new tab)⁠
  • Associate Dean
    College of Pharmacy-Downers Grove
  • Midwestern University, 555 31st St., Downers Grove, IL, 60515, United States

RESEARCH INTERESTS

Infectious Diseases Pharmacology
Pharmacometrics
Pharmacokinetics/Pharmacodynamics
Toxicology

GRANTS

  • EXTRAMURAL RESEARCH GRANT
    Antibacterial Resistance Leadership Group (ARLG)
    NIH UM1 subaward from Duke1 Dec 2024 - 30 Nov 2025
    People funded by this grant:
    • Scheetz M
  • EXTRAMURAL RESEARCH GRANT
    Antibacterial Resistance Leadership Group (ARLG)
    NIH UM1 subaward from Duke1 Dec 2023 - 30 Nov 2024
    People funded by this grant:
    • Scheetz M
  • EXTRAMURAL RESEARCH GRANT
    Elucidating the Temporal Mechnism of Vancomycin Kidney Toxicity as a Means to Prevent Injury
    NIH R21 with foreign subawards to University of West Attica ($72,576)and Universita Degli Studi Di Cagliari ($93,312)26 Jun 2023 - 31 May 2025
    People funded by this grant:
    • Scheetz M
  • EXTRAMURAL RESEARCH GRANT
    Elucidating the Temporal Mechnism of Vancomycin Kidney Toxicity as a Means to Prevent Injury
    NIH R21 with foreign subawards to University of West Attica ($72,576) and Universita Degli Studi Di Cagliari ($93,312)26 Jun 2023 - 31 May 2026
    People funded by this grant:
    • Scheetz M
  • EXTRAMURAL RESEARCH GRANT
    The PediatRic sEpiS induCed MODS: Relationship of Immune-phenotypes and antiBiotic Exposures (PRESCRIBE) Study
    NIH R01 subaward from Children's Hospital of Philadelphia19 Jun 2023 - 31 May 2028
    People funded by this grant:
    • Scheetz M
  • EXTRAMURAL RESEARCH GRANT
    Antibacterial Resistance Leadership Group (ARLG)
    NIH UM1 subaward from Duke1 Jun 2023 - 30 Nov 2023
    People funded by this grant:
    • Scheetz M
  • EXTRAMURAL RESEARCH GRANT
    A Randomized Clinical Trial of Continous vs. Intermittent Infusion Vancomycin: Effects on Measured GFR and Kidney Injury Biomarkers
    NIH R21 Clinical Trial subaward from the University of Kentucky20 Jan 2023 - 31 Dec 2024
    People funded by this grant:
    • Scheetz M
  • EXTRAMURAL RESEARCH GRANT
    A Randomized Clinical Trial of Continous vs. Intermittent Infusion Vancomycin: Effects on Measured GFR and Kidney Injury Biomarkers
    NIH R21 Clinical Trial subaward from the University of Kentucky20 Jan 2023 - 31 Dec 2025
    People funded by this grant:
    • Scheetz M
  • MWU INTRAMURAL GRANT
    A Mechanism Based Approach to Decrease Vancomycin Kidney Injury
    People funded by this grant:
    • Scheetz M